InsiderTrades

Form 4 for PGNY Progyny, Inc.

Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001551306-23-000108 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-05 2023-12-01 PGNY Livingston Mark S. CFO M - OptEx $3.95 +44.0K 102.4K +75% +$173.8K
DM 2023-12-05 2023-12-01 PGNY Livingston Mark S. CFO F - Tax $34.72 -27.3K 77.5K -26% -$948.0K
D 2023-12-05 2023-12-01 PGNY Livingston Mark S. CFO S - Sale+OE $34.62 -25.1K 50.0K -33% -$868.5K
D 2023-12-05 2023-12-01 PGNY Livingston Mark S. CFO M - OptEx $0.00 -44.0K 86.6K -34% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-01 M A 44,000 $3.95 102,377 D — —
2 Common Common Stock 2023-12-01 F D 2,394 $34.36 75,070 D — — (F1) Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
3 Common Common Stock 2023-12-01 F D 24,913 $34.75 77,464 D — — (F1) Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
4 Common Common Stock 2023-12-01 S D 25,087 $34.62 49,983 D — — (F2) Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 7, 2023. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.53 to $34.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission. Upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5 Derivative Stock Option (Right to Buy) 2023-12-01 M D 44,000 $0.00 86,627 D $3.95 · — to 2029-06-03 44,000 Common Stock (F4) 25% of the shares subject to the Option vested on June 4, 2020, with the remaining shares vesting in equal monthly installments thereafter through June 4, 2023, subject to the Reporting Person continuing to provide service through each such date.